Search result for 'gastroenterology'

Jujhar Group collaborates with Apollo Hospitals to establish a 625+ bed super-speciality hospital in Mohali, providing world-class medical services and setting a new benchmark in patient care.

Fortis Healthcare's consolidated net profit jumped 89% to Rs 254.3 crore in the December quarter, driven by exceptional item gains. Revenue from operations also saw a significant rise.

Lupin has entered into a patent license agreement with Takeda to commercialise Vonoprazan tablets, a novel gastrointestinal drug, in the Indian market. The drug will be marketed under the brand...

Nephro Care India's IPO opens June 28, aiming to raise over Rs 41 crore. The price band is set at Rs 85-90 per share, with the IPO closing on July 2. The funds will be used for a new...

Sun Pharma has partnered with Takeda to bring Vonoprazan, a novel gastrointestinal drug, to the Indian market. This partnership aims to provide patients with a new treatment option for reflux...

Torrent Pharmaceuticals has licensed Vonoprazan, a novel P-CAB for GERD treatment, from Takeda. The drug will be marketed in India under the brand name Kabvie.

Paras Healthcare has begun construction on a new 300-bed hospital in Gurugram, expanding its presence in the region. The facility will offer advanced medical technology and specialize in oncology,...

Max Healthcare Institute has acquired Alexis Multi-Speciality Hospital in Nagpur for Rs 412 crore, expanding its presence in Western and Central India. The hospital has been renamed Max Super...

Artemis Hospital, a leading healthcare provider in Gurugram, plans to increase its bed capacity to 800 by the end of FY 2023-24. The expansion includes a new Artemis Lite facility in Sector 82.

Lupin and Zydus Lifesciences have partnered to co-market Saroglitazar Mg, a drug for non-alcoholic fatty liver disease and nonalcoholic steato hepatitis, in India.